Amgen to Join Astellas on Developing Cancer, Bone Drugs

Amgen Inc., the world’s largest biotechnology company by sales, announced a partnership with Japanese drugmaker Astellas Pharma Inc. to bring five of its experimental therapies to market in that country.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.